Tenax Therapeutics Reports Beneficial Ownership Change by ADAR1 Capital Management
Tenax Therapeutics, Inc. filed a statement of changes in beneficial ownership of securities regarding ADAR1 Capital Management, LLC on October 21, 2026.
Stocks · News reference
Pomerantz Law Firm Announces Class Action Lawsuit Against Tenax Therapeutics, Inc.
Pomerantz LLP has filed a class action lawsuit against Tenax Therapeutics, Inc. and certain officers, alleging the company made false and misleading statements regarding its business and the efficacy of its drug candidate, TNX-103.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Tenax Therapeutics Temporarily Pauses Enrollment In LEVEL-2 Trial Of TNX-103 To Amend Criteria; Requests FDA Meeting
https://www.sec.gov/Archives/edgar/data/34956/000119312526417939/d139658dex991.htm
8-K filing — TENAX THERAPEUTICS, INC. (TENX)
Filed: 2026-10-08 AccNo: 0001193125-26-417939 Size: 4 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits